Navigation Links
VIA Pharmaceuticals Set to Join Russell Microcap Index
Date:6/27/2008

SAN FRANCISCO, June 27 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, will join the Russell Microcap Index when Russell Investments reconstitutes its family of U.S. indexes on June 27 after market close, according to a preliminary list of additions posted on http://www.russell.com

"We are pleased to have been selected for inclusion in this objective, market-driven index as we believe it reflects our continued progress and potential," said Lawrence K. Cohen, Ph.D., chief executive officer of VIA Pharmaceuticals.

Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Annual reconstitution of Russell indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000 Index and Russell Microcap. Total returns data for the Russell Microcap and other Russell Indexes is available at http://www.russell.com/Indexes/performance/daily_total_returns_us.asp.

About Russell

Russell Investments aims to improve financial security for people by providing strategic advice, world-class implementation, state-of-the-art performance benchmarks, and a range of institutional-quality investment products. With more than $213 billion in assets under management,
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Wyeth Pharmaceuticals Announces Organizational Change
2. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
3. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
4. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
5. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
6. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
7. Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
8. Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
9. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
10. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
11. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... OXFORD, England and CHICAGO ... Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a ... clinical and non-clinical data relating to the Company,s novel ... allergies will be presented at the 2015 European Academy ... in Barcelona, Spain on 6-10 ...
(Date:6/3/2015)... June 03, 2015 Photo-Eyewear™ ( ... name to PogoTec™, Inc. ( http://www.PogoTec.com ) to ... wearable device products and technologies it is developing and ... three business divisions, PogoTec™ will provide focused resources to ... follows: , , On-Track™ – There ...
(Date:6/3/2015)... Global Stem Cells Group ... plans to conduct Romania’s first ever stem cells harvesting ... with Miami-based Stem Cell Training, Inc., Cosmetic Surgeon ... Bone Marrow Stem Cell Training Course for medical professionals ... specialist practicing in Bucharest and Tel Aviv, Israel, and ...
(Date:6/2/2015)... , June 2, 2015 TapImmune, Inc. ... its institutional investors have reached an agreement whereby the ... short term warrants to provide the Company up to ... an effective S-1 registration statement. Under the restructured terms ... also call additional warrants which could result in a ...
Breaking Biology Technology:Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 3Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 2Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 3TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 2TapImmune Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation 3
... , ROCHESTER, N.Y., Sept. 21 According to Dr. ... Utah, "for the first time we have analyzed prostate cancer and normal ... XMRV virus] ... It was also more likely to be present in ... the least aggressive tumors and over 45 percent of the most aggressive ...
... , , , SAN CARLOS, ... it will be hosting a conference call to discuss today,s announcement of a ... a.m. Eastern Time (ET)/5:30 a.m. Pacific Time (PT). , , ... link that is posted on the home page of Nektar,s website: ...
... ... inventory Ultra-low Freezer and Liquid Nitrogen Tank samples and efficiently manage data of any ... ... announced the release of FreezerPro 2010, Frozen sample inventory and information management system (FSIIMS). ...
Cached Biology Technology:As Predicted: Chronic Virus Found Living in Tumors of the Prostate 2Nektar Therapeutics to Host Conference Call to Discuss Today's Announcement of a New Partnership for NKTR-118 and NKTR-119 2RURO Inc. Today Announced the Release of FreezerPro 2010, Frozen Sample Inventory and Information Management System 2
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... The National Human Genome Research Institute (NHGRI) of the ... three-year grant to establish a Wisconsin Center of Excellence ... effort between the University of Wisconsin in Madison, The ... be coordinated by the Medical College of Wisconsin. It ...
... rice to feed the world," says Dr. Robert Zeigler, director general ... and keep rice prices around US$300 a ton which allows ... for poor rice consumers we need to produce an additional ... for the next twenty years." Many countries do not have the ...
... CINCINNATIUsing an RNA-powered nanomotor, University of Cincinnati (UC) biomedical ... to transmit nanoscale material through a membrane. In ... Guo, PhD, members of the UC team inserted the ... into a lipid membrane. The resulting channel enabled them ...
Cached Biology News:Wisconsin Center of Excellence in Genomics Science established 2Wisconsin Center of Excellence in Genomics Science established 3'Land grabs' for rice production due to supply threats 2UC nanotech researchers develop artificial pore 2
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
... Mch3 Lyophilized solid. Highly active ... kinetics, cleavage of target substrates, and inhibitor screening. ... One unit is defined as the amount of enzyme ... 235400 per hour at 37 C at saturated substrate ...
HLA-DRbeta (DA2)...
Biology Products: